SJR 25 New Jersey Senate · 2024-2025 Regular Session

Establishes temporary Commission on Opioid Antidote Administration and Aftercare to study and report on procedures concerning administration of opioid antidotes to hospital patients.

SJR 25 establishes a temporary 15-member commission to study how hospitals in New Jersey and other states handle patient aftercare following naloxone (opioid antidote) administration. The commission will evaluate current hospital release procedures for these patients and recommend consistent, recovery-focused protocols for statewide implementation. It includes state health officials, hospital association leaders, and public members with expertise in addiction treatment or lived experience. The commission must submit its findings and recommendations to the Governor and Legislature within one year, after which it will expire. This resolution does not enact new laws but creates a study group to inform future policy.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2024
Committee Review
Floor Vote
Governor
Introduced Jan 9, 2024 Last action Jan 9, 2024
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
Jan 9, 2024
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Bob Singer
Bob Singer
RRepublican
NJ
30